GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sonoscape Medical Corp (SZSE:300633) » Definitions » YoY EBITDA Growth

Sonoscape Medical (SZSE:300633) YoY EBITDA Growth : -25.71% (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sonoscape Medical YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Sonoscape Medical's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -25.71%.

Sonoscape Medical's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.26.


Sonoscape Medical YoY EBITDA Growth Historical Data

The historical data trend for Sonoscape Medical's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sonoscape Medical YoY EBITDA Growth Chart

Sonoscape Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -49.93 -98.63 15,620.00 29.90 23.31

Sonoscape Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 167.18 11.71 -28.80 4.74 -25.71

Sonoscape Medical YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Sonoscape Medical's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(1.259-1.021)/ | 1.021 |
=23.31 %

Sonoscape Medical's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(0.26-0.35)/ | 0.35 |
=-25.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sonoscape Medical YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Sonoscape Medical's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Sonoscape Medical (SZSE:300633) Business Description

Traded in Other Exchanges
N/A
Address
Yuquan Road, 10th Floor,Yizhe Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518051
Sonoscape Medical Corp is a Chinese manufacturer of medical devices for ultrasound diagnostic systems and transducers. The company's product categories include Ultrasound, Endoscope which also includes video equipment, and Electrocardiography consisting of veterinary ECG and resting ECG. Ultrasound category covers color Doppler trolley systems, color Doppler HCU, B/W trolley systems, and probe, among others. The organization has a business presence in China and in other countries.

Sonoscape Medical (SZSE:300633) Headlines

No Headlines